Evidence map›Paper›PMID 24332986›Full record

ArticleNeurobiology of aging2014

Modulation of lipopolysaccharide-induced memory insult, γ-secretase, and neuroinflammation in triple transgenic mice by 5-lipoxygenase.

Yash B Joshi, Phillip F Giannopoulos, Jin Chu, Domenico Praticò

Erratum issuedAbstract read
In one paragraph

Article in Neurobiology of aging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Potential Use ofPlants (Basel, Switzerland) · 2022
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yash B JoshiCenter for Translational Medicine, Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA.
Phillip F GiannopoulosCenter for Translational Medicine, Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA.
Jin ChuCenter for Translational Medicine, Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA.
Domenico PraticòCenter for Translational Medicine, Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA. Electronic address: praticod@temple.edu.
Temple University · US

Funding

The Neurobiology of 5-LipoxygenaseR01AG033568 · NIA · TEMPLE UNIV OF THE COMMONWEALTH · PI PRATICO, DOMENICO · 2010 to 2014
$1.5M
The functional role of FLAP in Alzheimer's DiseaseR21NS071096 · NINDS · TEMPLE UNIV OF THE COMMONWEALTH · PI PRATICO, DOMENICO · 2011 to 2012
$421k
NIA NIH HHS AG033568NIA NIH HHS R01 AG033568NINDS NIH HHS NS071096NINDS NIH HHS R21 NS071096
6 · The paper itself

Abstract

Besides amyloid and tau pathology, a constant feature of Alzheimer's disease (AD) is an intense inflammatory response, which is considered an active player in its pathogenesis. The 5-Lipoxygenase (5LO) is a proinflammatory enzyme and an endogenous modulator of AD-like phenotype in mouse models of the disease. To further understand the role of 5LO in AD pathogenesis, we exposed the triple transgenic (3×Tg) and 3×Tg/5LO knockout mice to lipopolysaccharide (LPS), a known inducer of neuroinflammation, and evaluated its effect on their AD-like phenotype. 3×Tg mice treated with LPS manifested a worsening of behavior, γ-secretase up-regulation, and increased neuroinflammatory responses. These effects were completely prevented in 3×Tg mice genetically deficient for 5LO. By contrast, the absence of 5LO did not protect against increase in tau phosphorylation at specific epitopes that were mediated by the activation of the cyclin-dependent kinase 5. Our data demonstrate that the 5LO pathway affects key neuropathological features of the AD-like phenotype (behavior, abeta, microgliosis, astrocytosis) but not others (tau pathology) in the LPS-dependent neuroinflammation model. The opposite ways whereby 5LO influences the LPS-dependent effects in vivo supports the complex nature of the neuroinflammatory response in AD and its differential role in modulating amyloid and tau neuropathology.

Indexed as

Alzheimer DiseaseAmyloidogenic ProteinsAmyloid Precursor Protein SecretasesAnimalsArachidonate 5-LipoxygenaseCyclin-Dependent Kinase 5Disease Models, AnimalInflammationLipopolysaccharidesMemoryMiceMice, TransgenicPhosphorylationtau ProteinsUp-RegulationAmyloidogenic ProteinsAmyloid Precursor Protein SecretasesArachidonate 5-LipoxygenaseCyclin-Dependent Kinase 5Lipopolysaccharidestau ProteinsAlzheimer's diseaseAmyloid betaBehaviorLPSNeuroinflammationTransgenic mouse models

Identifiers

PMID24332986
PMCPMC3948206
OpenAlexW1972218887

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.